GSK turns to AI specialist Tempus for R&D productivity boost
pharmaphorum
OCTOBER 18, 2022
One of the first actions by GSK’s recently appointed chief scientific officer, Tony Wood, has been to expand a partnership with Tempus aimed at improving the big pharma’s R&D productivity, starting with its cancer pipeline. The post GSK turns to AI specialist Tempus for R&D productivity boost appeared first on.
Let's personalize your content